Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-02-03

Clinical Trial Update: Pharmacokinetic Profiles of Subcutaneous Enoxaparin for Thromboprophylaxis in Critically Ill Patients With Renal Failure Treated or Not With Continuous Veno-veinous Hemofiltration. [NA]

View source ↗

Summary

This clinical trial update describes pharmacokinetic profiling of subcutaneous enoxaparin for thromboprophylaxis in critically ill patients with renal failure, …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lovenox (enoxaparin)

Snippet

Sponsor: Clinique Saint Pierre Ottignies | Conditions: Thromboprophylaxis, Critical Illness | NA | Status: NOT_YET_RECRUITING